Compare Altria Group Inc (MO) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Altria Group Inc vs Summit Therapeutics Inc — how do they compare? Altria Group Inc trades at $73.25 (market cap $124.67B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Altria Group Inc is far larger — about 11.9× Summit Therapeutics Inc's market cap, and Altria Group Inc pays a 5.68% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MO | SMMT | |
|---|---|---|
Market Cap | $124.67B | $10.48B |
Sector | Consumer Staples | Health |
52-Week High | $74.66 | $29.32 |
52-Week Low | $54.72 | $13.05 |
Enterprise Value | $145.75B | $9.90B |
Dividend Yield | 5.68% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
